DE69424181D1 - Flunisolide aerosolformulierungen - Google Patents

Flunisolide aerosolformulierungen

Info

Publication number
DE69424181D1
DE69424181D1 DE69424181T DE69424181T DE69424181D1 DE 69424181 D1 DE69424181 D1 DE 69424181D1 DE 69424181 T DE69424181 T DE 69424181T DE 69424181 T DE69424181 T DE 69424181T DE 69424181 D1 DE69424181 D1 DE 69424181D1
Authority
DE
Germany
Prior art keywords
aerosol formulations
flunisolide
flunisolide aerosol
formulations
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69424181T
Other languages
English (en)
Other versions
DE69424181T2 (de
Inventor
Tsi-Zong Tzou
Robert K Schultz
Danna L Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22620133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69424181(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of DE69424181D1 publication Critical patent/DE69424181D1/de
Application granted granted Critical
Publication of DE69424181T2 publication Critical patent/DE69424181T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
DE69424181T 1993-12-20 1994-11-15 Flunisolide aerosolformulierungen Expired - Lifetime DE69424181T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17050993A 1993-12-20 1993-12-20
PCT/US1994/013203 WO1995017195A1 (en) 1993-12-20 1994-11-15 Flunisolide aerosol formulations

Publications (2)

Publication Number Publication Date
DE69424181D1 true DE69424181D1 (de) 2000-05-31
DE69424181T2 DE69424181T2 (de) 2000-10-19

Family

ID=22620133

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69424181T Expired - Lifetime DE69424181T2 (de) 1993-12-20 1994-11-15 Flunisolide aerosolformulierungen

Country Status (12)

Country Link
US (2) US5776433A (de)
EP (1) EP0735884B1 (de)
JP (1) JPH09506896A (de)
AU (1) AU680967B2 (de)
CA (1) CA2178473C (de)
DE (1) DE69424181T2 (de)
DK (1) DK0735884T3 (de)
ES (1) ES2145254T3 (de)
NO (1) NO313123B1 (de)
NZ (1) NZ276637A (de)
PT (1) PT735884E (de)
WO (1) WO1995017195A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
EP0617610B1 (de) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Aerosolzusammensetzungen für arzneimittelsuspensionen
DE69424181T2 (de) * 1993-12-20 2000-10-19 Minnesota Mining & Mfg Flunisolide aerosolformulierungen
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6197280B1 (en) * 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JP2001519301A (ja) * 1997-10-13 2001-10-23 バルワー エス．アー． バルブ用シールジョイント
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
ME00220B (me) 2000-05-22 2010-10-10 Chiesi Farm Spa Stabilne farmaceutske formulacije rastvora za inhalatore odmjerene doze pod pritiskom
EP1241113A1 (de) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhalator mit Mitteln um chemische Stabilität der darin enthaltenen medizinischen Aerosollösung zu verbessern
WO2002092154A1 (en) * 2001-04-26 2002-11-21 New England Pharmaceuticals, Inc. Metered dose delivery device for liquid and powder agents
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
DK1273292T3 (da) 2001-07-02 2004-10-04 Chiesi Farma Spa Optimeret tobramycinformulering til aerosoldannelse
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1458354A1 (de) * 2001-12-21 2004-09-22 3M Innovative Properties Company Ionenpaarkomplexe enthaltende medizinische aerosolzusammensetzung
HUE049426T2 (hu) * 2002-03-01 2020-09-28 Chiesi Farm Spa Szuperfinom formoterolkészítmény
TW200409746A (en) * 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
WO2005032521A2 (en) * 2003-10-02 2005-04-14 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20060188449A1 (en) * 2003-10-03 2006-08-24 Jane Hirsh Topical aerosol foams
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1595531A1 (de) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stabile Arzneimittellösung für Druckdosierinhalatoren
US20050255048A1 (en) * 2004-05-15 2005-11-17 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
GEP20105040B (en) 2005-02-25 2010-07-12 Chiesi Farm Spa Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
CA2607148C (en) 2005-05-18 2014-12-23 Nektar Therapeutics Valves, devices, and methods for endobronchial therapy
US8277780B2 (en) * 2005-05-27 2012-10-02 Taro Pharmaceutical North America, Inc. Stable liquid desoximethasone compositions with reduced oxidized impurity
MX348936B (es) 2005-09-29 2017-07-03 Nektar Therapeutics Formulaciones de antibioticos, dosis unitarias, equipos y metodos.
US8227027B2 (en) 2007-12-07 2012-07-24 Presspart Gmbh & Co. Kg Method for applying a polymer coating to an internal surface of a container
US8652443B2 (en) * 2008-02-14 2014-02-18 Precision Dermatology, Inc. Foamable microemulsion compositions for topical administration
WO2010025821A1 (de) 2008-09-04 2010-03-11 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Monoterpene für die behandlung von atemwegserkrankungen, insbesondere bronchopulmonalen erkrankungen
US20110166063A1 (en) 2008-09-19 2011-07-07 Nektar Therapeutics Polymer conjugates of therapeutic peptides
US20100141969A1 (en) * 2008-12-08 2010-06-10 Brazier David B Method and Apparatus for Making Liquid Flexographic Printing Elements
UA118087C2 (uk) 2009-10-01 2018-11-26 Адер Фармасьютікалз, Інк. Композиція кортикостероїду, застосована перорально
EP2512438B1 (de) 2009-12-16 2017-01-25 3M Innovative Properties Company Formulierungen und verfahren zur steuerung der mdi-partikelgrössenfreisetzung
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (de) * 1956-03-21 1900-01-01
US2885427A (en) * 1956-11-15 1959-05-05 Dow Chemical Co Fluorination of trichloroethylene
US4083954A (en) * 1975-04-04 1978-04-11 Kao Soap Co., Ltd. Aerosol composition
US4933168A (en) * 1975-05-27 1990-06-12 Syntex Pharmaceuticals International Limited Stable, crystalline flunisolide
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CH634480A5 (de) * 1977-11-25 1983-02-15 Schwarzkopf Gmbh Hans Unter druck stehendes aerosolpraeparat.
US4273710A (en) * 1979-05-21 1981-06-16 Syntex Corporation Process for preparing flunisolide
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
US4851211A (en) * 1986-11-25 1989-07-25 Abbott Laboratories LHRH analog formulations
JPH0730311B2 (ja) * 1987-09-21 1995-04-05 ダイキン工業株式会社 冷 媒
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
ES2071306T3 (es) * 1990-03-23 1995-06-16 Minnesota Mining & Mfg El uso de tensioactivos fluorados solubles para la preparacion de formulaciones aerosoles dosificadas.
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE69231994T3 (de) * 1991-06-10 2010-01-21 Schering Corp. Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
IL102130A0 (en) * 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
EP0617610B1 (de) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Aerosolzusammensetzungen für arzneimittelsuspensionen
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants
AU679510B2 (en) * 1993-03-17 1997-07-03 Minnesota Mining And Manufacturing Company Aerosol formulation containing a diol-diacid derived dispersing aid
DE69424181T2 (de) * 1993-12-20 2000-10-19 Minnesota Mining & Mfg Flunisolide aerosolformulierungen
US5695473A (en) * 1994-07-27 1997-12-09 Sims Deltec, Inc. Occlusion detection system for an infusion pump

Also Published As

Publication number Publication date
DK0735884T3 (da) 2000-10-09
EP0735884B1 (de) 2000-04-26
US5776433A (en) 1998-07-07
CA2178473A1 (en) 1995-06-29
JPH09506896A (ja) 1997-07-08
NO962585D0 (no) 1996-06-18
WO1995017195A1 (en) 1995-06-29
AU680967B2 (en) 1997-08-14
US5980867A (en) 1999-11-09
DE69424181T2 (de) 2000-10-19
ES2145254T3 (es) 2000-07-01
CA2178473C (en) 2004-08-24
EP0735884A1 (de) 1996-10-09
PT735884E (pt) 2000-09-29
AU1098695A (en) 1995-07-10
NO313123B1 (no) 2002-08-19
NO962585L (no) 1996-06-18
NZ276637A (en) 1997-07-27

Similar Documents

Publication Publication Date Title
DK0735884T3 (da) Flunisolid-aerosolformuleringer
EE9700138A (et) Aerosoolravimvormid
DE69413387T2 (de) Aerosol-abgabevorrichtung
DK0990437T4 (da) Aerosolsammensætninger
NO920987D0 (no) Farmasoeytiske aerosolformuleringer
NO944526D0 (no) Medisinsk aerosolformulering
DK0619797T3 (da) Aerosolventiler
DE69502111D1 (de) Aerosolabgabevorrichtung
BR9508597A (pt) Composição antitranspirante em aerossol
DE69600409T2 (de) Aerosol-Behälter
ID18137A (id) Formulasi-formulasi aerosol mometason furoat bebas klorofluorokarbon
PT100649A (pt) Valvula de aerossol
DE59406010D1 (de) Dispenser
EE9400195A (et) Aerosoolpihusti
DE69314814T2 (de) Aerosolventil
DE29615896U1 (de) Aerosolzusammensetzung
SE9404469D0 (sv) Aerosol formulations
SE9502452D0 (sv) Aerosol formulations
DE9307343U1 (de) Aerosolgenerator
DK57893D0 (da) Sprinkler
DE9418639U1 (de) Spraydosen
KR950016744U (ko) 방향기
GB9323943D0 (en) Aerosol devices
FI1012U1 (fi) Foerpackning foer en pensel
GB9306212D0 (en) Aerosol

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings